Tradjenta (Boehringer Ingelheim Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Tradjenta drug offered from Boehringer Ingelheim Pharmaceuticals, Inc.. This Dipeptidyl Peptidase 4 Inhibitors [MoA],Dipeptidyl Peptidase 4 Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Boehringer Ingelheim Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | linagliptin |
| SUBSTANCE NAME: | LINAGLIPTIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Dipeptidyl Peptidase 4 Inhibitors [MoA],Dipeptidyl Peptidase 4 Inhibitor [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-05-09 |
| END MARKETING DATE: | 0000-00-00 |
Tradjenta HUMAN PRESCRIPTION DRUG Details:
| Item Description | Tradjenta from Boehringer Ingelheim Pharmaceuticals, Inc. |
| LABELER NAME: | Boehringer Ingelheim Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/1) |
| START MARKETING DATE: | 2011-05-09 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0597-0140_1135e6c8-c2ae-d958-20ba-6c1eda889aa2 |
| PRODUCT NDC: | 0597-0140 |
| APPLICATION NUMBER: | NDA201280 |
Other LINAGLIPTIN Pharmaceutical Manufacturers / Labelers:
